Abstract:

Objective To study the therapeutic effect of beraprost sodium combined with NiaoduqingGranules on improving the residual renal function of hemodialysis patients. Methods Eighty patients with chronickidney disease from March 2019 to April 2021 who underwent haemodialysis therapy were selected and randomlydivided into study group（n = 40）and control group（n = 40）. The patients in the control group were treated withhemodialysis，while the patients in the investigation group were treated with beraprost sodium combined with Nia⁃oduqing Granules. The indexes of residual renal function were compared between the two groups. Results Thehighest level of serum creatinine and BUN in the study group was significantly lower than that in the control group，but the level of eGFRand RRF was significantly higher than that in the control group（P < 0.05）. The residualrenal function and KT/V value of dialysis in the study group were significantly better than those in the control group（P < 0.05）. Conclusion Beraprost sodium combined with Niaodujing Granules can effectively protect the residualrenal function of hemodialysis patients，improve the adequacy of hemodialysis，and the quality of life of patients，and delay the development of the disease.

Key words:

chronic kidney disease, sodium berprost, niaoduqing granules, residual renal function